Cerus reported $-8983000 in EBITDA for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ebitda Change
Atrion ATRI:US 11.2M 1.6M
Cerulean Pharma CERU:US $ -8.4M 1.14M
Cerus CERS:US $ -8.98M 2.83M
Cytori Therapeutics CYTX:US $ -3.78M 0.27M
GRIFOLS GRF:SM € 329.18M 78.53M
Haemonetics HAE:US $ 112.29M 46.15M
Meridian Bioscience VIVO:US $ 40.87M 16.12M
Nuvasive NUVA:US $ 51.8M 4.46M
Orasure Technologies OSUR:US $ -12.33M 6.18M
Quidel QDEL:US $ 640.48M 241.54M
Sientra SIEN:US $ -14.35M 1.84M
Staar Surgical STAA:US $ 13.12M 4.79M
Terumo 4543:JP Y 64822M 21298M
Utah Medical Products UTMD:US 6.92M 1.2M